Related Experiment Video
Updated: Nov 29, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Subclinical hyperthyroidism and the risk of developing cardiovascular disease - a systematic review
Stine Bech Smedegaard1, Anne Lene Riis, Morten Krogh Christiansen
1Stinsmed@rm.dk.
Insights
Subclinical hyperthyroidism (SH) is linked to increased risks of atrial fibrillation (AF) and heart failure (HF). However, current research does not support a connection between SH and myocardial infarction (MI) or cardiovascular mortality.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- The cardiovascular risks associated with subclinical hyperthyroidism (SH) remain a subject of ongoing debate.
- SH is a condition characterized by suppressed thyroid-stimulating hormone levels with normal circulating thyroid hormone concentrations.
Purpose of the Study:
- To systematically review the existing literature on the association between subclinical hyperthyroidism and major cardiovascular outcomes.
- To evaluate the evidence linking SH to atrial fibrillation (AF), heart failure (HF), myocardial infarction (MI), and cardiovascular mortality.
Main Methods:
- A comprehensive literature search was conducted using the PubMed database.
- Included studies were observational, focused on SH in human subjects, and reported on outcomes such as AF, HF, MI, or cardiovascular mortality.
- Studies published in English or Danish with euthyroid controls were selected.
Main Results:
- A total of 33 observational studies were included in the review.
- Evidence from 13 studies supported an association between SH and an increased risk of AF.
- Evidence from five studies supported an association between SH and an increased risk of HF.
Conclusions:
- The current body of evidence suggests a significant association between subclinical hyperthyroidism and increased risks of atrial fibrillation and heart failure.
- The reviewed literature did not establish a clear association between subclinical hyperthyroidism and the risk of myocardial infarction or overall cardiovascular mortality.
Introduction:
It is debated whether the presence of subclinical hyperthyroidism (SH) constitutes an increased risk of cardiovascular disease. This review presents a summary of the literature examining the association between SH and atrial fibrillation (AF), heart failure (HF), myocardial infarction (MI) and cardiovascular mortality.
Methods:
A systematic literature search of the PubMed database was performed. Studies were included if they were of observational design, about SH in humans, and had AF, HF, MI and/or cardiovascular mortality as outcome, were published in either Danish or English language and included euthyroid controls.
Results:
A total of 33 papers were suitable for inclusion. Thus, 13 papers on AF and five papers on HF were included for review and supported an association between SH and AF and HF, respectively. In all, 14 papers on MI and 15 papers on cardiovascular mortality were included for review; but, overall, they did not support an association between SH and MI or cardiovascular mortality.
Conclusions:
Based on our review, current literature supports an association between SH and AF and HF, respectively; but not between SH and MI or cardiovascular mortality.
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Hypertension III: Clinical Manifestations and Diagnostic Studies
Atherosclerosis III: Management
Hypertension II: Pathophysiology